Keeley Teton Advisors LLC Increases Position in Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

Keeley Teton Advisors LLC increased its stake in Sabra Health Care REIT, Inc. (NASDAQ:SBRAGet Rating) by 13.3% in the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 591,526 shares of the real estate investment trust’s stock after acquiring an additional 69,361 shares during the period. Sabra Health Care REIT comprises approximately 0.9% of Keeley Teton Advisors LLC’s portfolio, making the stock its 14th largest position. Keeley Teton Advisors LLC owned about 0.26% of Sabra Health Care REIT worth $8,808,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Weiss Multi Strategy Advisers LLC boosted its position in Sabra Health Care REIT by 230.8% during the first quarter. Weiss Multi Strategy Advisers LLC now owns 992,410 shares of the real estate investment trust’s stock valued at $14,777,000 after buying an additional 692,438 shares during the period. Advisors Asset Management Inc. boosted its position in Sabra Health Care REIT by 34.2% during the first quarter. Advisors Asset Management Inc. now owns 153,741 shares of the real estate investment trust’s stock valued at $2,289,000 after buying an additional 39,170 shares during the period. Jane Street Group LLC boosted its position in Sabra Health Care REIT by 604.1% during the first quarter. Jane Street Group LLC now owns 495,994 shares of the real estate investment trust’s stock valued at $7,385,000 after buying an additional 425,549 shares during the period. Meiji Yasuda Asset Management Co Ltd. purchased a new stake in Sabra Health Care REIT during the first quarter valued at about $597,000. Finally, Eaton Vance Management boosted its position in Sabra Health Care REIT by 585.3% during the first quarter. Eaton Vance Management now owns 13,740 shares of the real estate investment trust’s stock valued at $205,000 after buying an additional 11,735 shares during the period. 87.67% of the stock is currently owned by hedge funds and other institutional investors.

Sabra Health Care REIT Price Performance

Shares of NASDAQ SBRA opened at $14.49 on Wednesday. Sabra Health Care REIT, Inc. has a fifty-two week low of $11.44 and a fifty-two week high of $16.60. The company has a 50 day simple moving average of $15.14 and a two-hundred day simple moving average of $14.12. The company has a market capitalization of $3.35 billion, a price-to-earnings ratio of 76.27 and a beta of 1.31. The company has a debt-to-equity ratio of 0.75, a quick ratio of 3.97 and a current ratio of 3.97.

Sabra Health Care REIT Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, August 31st. Stockholders of record on Wednesday, August 17th were issued a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 8.28%. The ex-dividend date of this dividend was Tuesday, August 16th. Sabra Health Care REIT’s payout ratio is 631.61%.

Wall Street Analysts Forecast Growth

SBRA has been the subject of several analyst reports. Citigroup upped their price target on shares of Sabra Health Care REIT to $15.50 in a research report on Monday, August 22nd. Jefferies Financial Group downgraded shares of Sabra Health Care REIT from a “buy” rating to a “hold” rating and lowered their price objective for the company from $15.00 to $14.00 in a research note on Thursday, June 30th. Barclays upped their price objective on shares of Sabra Health Care REIT to $15.00 in a research note on Tuesday, August 9th. Mizuho raised shares of Sabra Health Care REIT from a “neutral” rating to a “buy” rating and lowered their price objective for the company from $16.00 to $15.00 in a research note on Wednesday, May 25th. Finally, Capital One Financial assumed coverage on shares of Sabra Health Care REIT in a research note on Friday, June 3rd. They set an “equal weight” rating and a $15.50 price objective for the company. Seven investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $15.91.

Sabra Health Care REIT Company Profile

(Get Rating)

As of March 31, 2022, Sabra's investment portfolio included 416 real estate properties held for investment. This consists of (i) 279 Skilled Nursing/Transitional Care facilities, (ii) 59 Senior Housing communities (Senior Housing – Leased), (iii) 50 Senior Housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), (iv) 13 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), one asset held for sale, one investment in a sales-type lease, 16 investments in loans receivable (consisting of (i) two mortgage loans, (ii) one construction loan and (iii) 13 other loans), seven preferred equity investments and one investment in an unconsolidated joint venture.

Further Reading

Institutional Ownership by Quarter for Sabra Health Care REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.